Article Information
History
- January 10, 2024.
Article Versions
- You are currently viewing Version 1 of this article (January 10, 2024 - 10:06).
- Version 2 (January 15, 2024 - 05:36).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Bo Zheng1,†,
- Bronner Gonçalves2,†,
- Pengfei Deng3,†,
- Weibing Wang1,4,
- Jie Tian1,
- Xueyao Liang1,
- Ye Yao5,* and
- Caoyi Xue3,*
- 1Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China
- 2Department of Comparative Biomedical Sciences, School of Veterinary Medicine, University of Surrey, Guildford, UK
- 3Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai, 200120, China
- 4Key Laboratory of Public Health Safety of Ministry of Education, Fudan University, Shanghai 200032, China
- 5School of Public Health, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China
- ↵*Corresponding authors: Dr. Ye Yao, School of Public Health, Fudan University, 138 Yi Xue Yuan Road, Shanghai 200032, China (e-mail: yyao{at}fudan.edu.cn). Dr. Caoyi Xue, Shanghai Pudong New Area Center for Disease Control and Prevention, 3039 Zhangyang Road, Shanghai, 200120, China (e-mail: xuecaoyi83{at}163.com)
↵† These authors contributed equally to this work.
Posted January 10, 2024.
Protection afforded by post-infection SARS-CoV-2 vaccine doses: a cohort study in Shanghai
